alpha-Fenchyl acetate is a monoterpene ester with a fir-needle, pine-like odor profile and a modest but explicit place in the AromaForge archive through galbanum essential oil. Compared with generic fenchyl acetate, the isomer-specific public literature is limited, but there is enough live source support to document identity, odor, archive occurrence, and one recent rat study on fenchyl acetate's diuretic activity. Because much of the broader literature treats mixed or generic fenchyl acetate rather than the alpha isomer specifically, this record should keep its evidence labels conservative.
Chemical identity and composition
PubChem assigns alpha-fenchyl acetate to the stereospecific acetate with CID 6427102 and CAS 4057-31-2, while generic fenchyl acetate records often use CID 107217 and CAS 13851-11-1. The local galbanum oil file uses the broader fenchyl-acetate CAS in its composition table, so this constituent record keeps the alpha-isomer identity explicit and notes that cross-source registry mismatch.
Aroma and practical use
- Use the recorded fir needle, fresh, sweet, pine, camphoraceous, coniferous, piney descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
rat diuretic activity
A 2023 ACS Omega study reported that fenchyl acetate increased urine output along with sodium, potassium, creatinine, and uric-acid excretion in rats, showed no acute toxicity at 2000 mg/kg in the OECD-425 design, and suggested nitric-oxide involvement in the diuretic response.
Measured: urine output, electrolyte excretion, acute toxicity, and mechanism probes
This experimental finding does not establish benefit, dose or safety in people using this blend.
pelargonium occurrence
A Natural Product Research paper identified alpha-fenchyl acetate as a major component of Pelargonium quercetorum essential oil at 20.63%, supporting that the alpha isomer can occur as a prominent natural constituent in some plant oils.
Measured: relative abundance in plant volatile profile
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedThe alpha-fenchyl acetate Good Scents page listed no hazard statements or precautionary statements, but also marked oral, dermal, and inhalation toxicity as not determined.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
The reviewed animal study reported no acute mortality or overt toxicity at 2000 mg/kg in rats, but that is preclinical oral evidence and not a topical-use safety standard.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
No isomer-specific IFRA dermal limit for alpha-fenchyl acetate was verified in this pass.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
How the effects were investigated
nitric oxide linked diuresis
In one rat study, fenchyl acetate increased urine output and electrolyte excretion and the authors' antagonist work supported nitric-oxide involvement in the observed diuretic effect.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- Public sources do not cleanly separate alpha-fenchyl acetate from broader fenchyl acetate records, so some pharmacology evidence may be isomer-ambiguous.
- No human clinical studies specific to alpha-fenchyl acetate were verified in the reviewed public sources.
- No isomer-specific dermal-limit or sensitization standard for alpha-fenchyl acetate was located in the reviewed public sources.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.